Atrial septal defect in end-stage liver disease children before and after liver transplantation

被引:9
|
作者
Concejero, Allan [1 ]
Chen, Chao-Long [1 ]
Liang, Chi-Di [2 ]
Wang, Chih-Chi [1 ]
Wang, Shih-Ho [1 ]
Lin, Chih-Che [1 ]
Liu, Yeuh-Wei [1 ]
Yong, Chee-Chien [1 ]
Yang, Chin-Hsiang [1 ]
Jawan, Bruno [3 ]
Cheng, Yu-Fan [4 ]
机构
[1] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Liver Transplantat Program, Dept Surg, Niao Sung 833, Kaohsiung, Taiwan
[2] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat Cardiol, Niao Sung 833, Kaohsiung, Taiwan
[3] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Anesthesiol, Niao Sung 833, Kaohsiung, Taiwan
[4] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Diagnost Radiol, Niao Sung 833, Kaohsiung, Taiwan
关键词
D O I
10.1016/j.surg.2007.08.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background and Objective. Atrial septal defect (ASD) is a common congenital heart defect. The course and impact of hemodynamically insignificant ASD in end-stage liver disease (ESLD) patients remains to be elucidated. Our objective is to present our experience in live donor liver transplantation in children with secundum type of ASD and to find out whether ASD has an impact on the outcome of liver transplantation. Patients and Methods. Fourteen recipients (7 male, 7 female) whose median age was 14.2 months (range, 8-28) were included. The diagnosis of secundum type of ASD was confirmed by transthoracic 2-dimensional Doppler echocardiography preoperatively. The mean Child's score was 9.9, and the mean Pediatric End-stage Liver Disease Score was 14.7. The ASD were classified based on physiologic-hemodynamic (insignificant vs significant) and structural size (small [<= 4 mm], medium [5-9 mm], or large [>= 10 mm]) parameters. Only I patient showed hemodynamically significant ASD based on echocardiography and cardiac catheterization findings. Results. Six small ASD spontaneously closed during the waiting period for transplantation. Four small ASD spontaneously closed posttransplant. The medium- and large-sized ASD persisted or increased in size posttransplantation. There were no perioperative cardiac complications. There were no neurologic complications. All patients are alive with the original grafts. The median follow-up was 49.7 months (range, 19.8-79.4). Conclusion. Hemodynamic insignificant ASD seems to not impact the outcome of liver transplantation in children with ESLD. Further, this series demonstrated that transplantation can be successfully and safely performed in the presence of hemodynamically stable patients with small- to large-sized ASD.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [41] Integration of Palliative Care in End-Stage Liver Disease and Liver Transplantation
    Potosek, Jamie
    Curry, Michael
    Buss, Mary
    Chittenden, Eva
    JOURNAL OF PALLIATIVE MEDICINE, 2014, 17 (11) : 1271 - 1277
  • [42] TC-99-HM-PAO SPECT IN END-STAGE LIVER-DISEASE BEFORE AND AFTER LIVER-TRANSPLANTATION
    DAM, M
    PIZZOLATO, G
    BURRA, P
    ROSSATO, A
    ORLANDO, F
    CHIERICHETTI, F
    BATTISTIN, L
    NEUROLOGY, 1994, 44 (04) : A251 - A251
  • [43] Carbohydrate-deficient transferrin:: Diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation
    Heinemann, A
    Stemeck, M
    Kuhlencordt, R
    Rogiers, X
    Schulz, KH
    Queen, B
    Wischhusen, F
    Püschel, K
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (08) : 1806 - 1812
  • [44] HYPOTHALAMIC-PITUITARY-TESTICULAR FUNCTION IN END-STAGE NONALCOHOLIC LIVER-DISEASE BEFORE AND AFTER LIVER-TRANSPLANTATION
    HANDELSMAN, DJ
    STRASSER, S
    MCDONALD, JA
    CONWAY, AJ
    MCCAUGHAN, GW
    CLINICAL ENDOCRINOLOGY, 1995, 43 (03) : 331 - 337
  • [45] Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease
    Zhang Ying-cai
    Zhang Qi
    Li Hua
    Zhang Jian
    Wang Gen-shu
    Xu Chi
    Yi Shu-hong
    Yi Hui-min
    Cai Chang-jie
    Lu Min-qiang
    Yang Yang
    Chen Gui-hua
    CHINESE MEDICAL JOURNAL, 2011, 124 (24) : 4229 - 4235
  • [46] Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease
    ZHANG YingcaiZHANG QiLI HuaZHANG JianWANG GenshuXU ChiYI ShuhongYI Huimin CAI ChangjieLU MinqiangYANG Yang and CHEN Guihua Liver Transplantation CenterThird Affiliated Hospital of Sun Yatsen UniversityGuangzhouGuangdong China Guangdong Provincial Key Laboratory of Liver Disease GuangzhouGuangdong China
    中华医学杂志(英文版), 2011, (24) : 4229 - 4235
  • [47] Impact of pancreatic comorbidities in patients with end-stage liver disease on outcome after liver transplantation
    Darstein, Felix
    Koenig, Christina
    Hoppe-Lotichius, Maria
    Grimm, Daniel
    Knapstein, Johanna
    Mittler, Jens
    Lang, Hauke
    Galle, Peter Robert
    Zimmermann, Tim
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (03) : 281 - 285
  • [48] Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue, James R.
    Nelson, David R.
    Reed, Alan I.
    Hanto, Douglas W.
    Curry, Michael P.
    PROGRESS IN TRANSPLANTATION, 2011, 21 (03) : 207 - 214
  • [49] Calciphylaxis in end-stage liver and renal disease patients before and after transplant
    Couri, Thomas
    Stier, Matthew
    Mikolajczyk, Adam
    Aronsohn, Andrew
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [50] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123